Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Garel

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Addiction (Abingdon, England)|March 11, 2026
Measuring the psychoactive effects of ketamine in alcohol use disorder: When assessment shapes experienceChristina McAnulty, Nicolas Garel
Journal of Psychiatry & Neuroscience : JPN|October 29, 2019
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiencyNicolas Garel, Ridha Joober
Journal of Psychiatry & Neuroscience : JPN|February 26, 2020
Are mental disorders orphan diseases?Nicolas Garel, Ridha Joober
Journal of Psychiatry & Neuroscience : JPN|January 19, 2021
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorderNicolas Garel, Kyle Greenway, Ridha Joober
Journal of Psychiatry & Neuroscience : JPN|August 22, 2020
Treating anxious syndromes with pregabalin in patients with psychosisNicolas Garel, David Bloom, Ridha Joober
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 28, 2024
Advancing research: a commentary on the untapped potential of acceptance and commitment therapy in alcohol use disorder treatmentNicolas Garel, Kimberly L Brodsky, Michael J Ostacher
Journal of Addiction Medicine|April 3, 2025
Online Drug Markets and Implications for Addiction Medicine: A Narrative Literature ReviewNicolas Garel, Priyanka Goonetilleke, Artem Kuriksha, et al.
Addiction (Abingdon, England)|January 12, 2024
Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022Nicolas Garel, Steven Tate, Kristin Nash, et al.
Journal of Psychiatry & Neuroscience : JPN|May 27, 2021
Serotonin syndrome: SSRIs are not the only culpritNicolas Garel, Kyle T. Greenway, Karim Tabbane, et al.
Expert Review of Clinical Pharmacology|June 2, 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatmentsKyle T Greenway, Nicolas Garel, Lisa Jerome, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Addiction (Abingdon, England)|March 11, 2026
Measuring the psychoactive effects of ketamine in alcohol use disorder: When assessment shapes experienceChristina McAnulty, Nicolas Garel
Journal of Psychiatry & Neuroscience : JPN|October 29, 2019
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiencyNicolas Garel, Ridha Joober
Journal of Psychiatry & Neuroscience : JPN|February 26, 2020
Are mental disorders orphan diseases?Nicolas Garel, Ridha Joober
Journal of Psychiatry & Neuroscience : JPN|January 19, 2021
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorderNicolas Garel, Kyle Greenway, Ridha Joober
Journal of Psychiatry & Neuroscience : JPN|August 22, 2020
Treating anxious syndromes with pregabalin in patients with psychosisNicolas Garel, David Bloom, Ridha Joober
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 28, 2024
Advancing research: a commentary on the untapped potential of acceptance and commitment therapy in alcohol use disorder treatmentNicolas Garel, Kimberly L Brodsky, Michael J Ostacher
Journal of Addiction Medicine|April 3, 2025
Online Drug Markets and Implications for Addiction Medicine: A Narrative Literature ReviewNicolas Garel, Priyanka Goonetilleke, Artem Kuriksha, et al.
Addiction (Abingdon, England)|January 12, 2024
Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022Nicolas Garel, Steven Tate, Kristin Nash, et al.
Journal of Psychiatry & Neuroscience : JPN|May 27, 2021
Serotonin syndrome: SSRIs are not the only culpritNicolas Garel, Kyle T. Greenway, Karim Tabbane, et al.
Expert Review of Clinical Pharmacology|June 2, 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatmentsKyle T Greenway, Nicolas Garel, Lisa Jerome, et al.
Pageof 4